August 11, 2020
BURLINGTON, N.C. --(BUSINESS WIRE)--Aug. 11, 2020-- Labcorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced details of a no charge antibody testing program in response to federal health authorities’ request to increase donations of COVID-19 blood plasma. Plasma with COVID-19 antibodies may be helpful when treating patients with an active COVID-19 infection and is being evaluated as a possible treatment.
